ProteinChip technology: A new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-II and their glycosylated products in patients with diabetes and cardiovascular disease

Journal of Proteome Research

Volumn 1, Issue 4, 2002, Pages 375-380

  Dayal, Bishambar ^a,b   Ertel, Norman H ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular disease; Diabetes; HDL apolipoprotein A I; Matrix assisted laser desorption ionization mass spectrometry (MALDI MS); ProteinChip; Surface enhanced laser desorption ionization (SELDI); Time of flight mass spectrometry (TOF MS)

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN;

ARTICLE; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; DEVICE; DIABETES MELLITUS; GLYCOSYLATION; HUMAN; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SAMPLING;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GLYCOSYLATION; HUMANS; MOLECULAR WEIGHT; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0036665376     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr010008n     Document Type: Article

References (48)

1. Frank, P. G.; Marcel, Y. L. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 2000, 41, 853-872 and references cited therein.
2. Koppaka, V.; Axelsen, P. H. Lipoprotein A-I structure. Trends Cardiovasc. Med. 1999, 9, 192-195.
3. Segrest, J. P.; Li, L.; Anantharamaiah, G. M.; Harvey, S. C.; Liadaki, K. N.; Zann. Structure and function of human apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. 2000, 11, 105-115.
4. Hedric, C. H.; Castellani, L. W.; Wong, H.; Lusis, A. J. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions. J. Lipid Res. 2001, 42, 563-570.
5. Young, S. G.; Fielding, C. J. The ABC's of cholesterol efflux. Nature Genet. 1999, 22, 316-31846.
6. milano has reduced capacity, compared wtih wild-type apolipoprotein A-I, to recruit membrane cholesterol. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 1637, 1643.
7. Brinton E. A.; Eisenberg S.; Breslow J. L. Elevated high-density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 1989, 84, 262-269.
8. Nakamura, T.; Fox-Robichaud A.; Kikkawa R.; Kashiwagi A.; Kojima H.; Fujimiya, M.; Wong N. C. W. Transcription factors and age-related decline in apolipoprotein A-I expression. J. Lipid Res. 1999, 40, 1709-1718.
9. Horowitz, B. S.; Goldberg I. J.; Meran J.; Vanni, T. M.; Ramakrishnan, R.; Ginsberg, H. N. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high-density lipoprotein cholesterol. J. Clin. Invest. 1993, 91, 1743-1752.
10. Curtis, L. K.; Witztum, J. L. Plasma apolipoproteins Al, All, B, Cl, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985, 34, 452-461.
11. Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46, 223-234.
12. Schmidt, A. M.; Yan, S. D.; Wautier, J. L.; Stern, D. Activation of receptor for advanced glycation end products. Circ. Res. 1998, 84, 489-497.
13. Rudd, M. P.; Endo, T.; Colominas, C.; Groth, D.; Wheeler, S. F.; Harvey, D. J.; Wormald, M. R.; Serban, H.; Prusiner, S. B.; Kobata, A.; Dwek, R. A. Glycosylation differences between the normal and pathogenic prion protein isoforms. Biochemistry 1999, 23, 13044-13049.
14. Sprecher, D. L.; Taam, L.; Brewer, H. B., Jr. Two-dimensionalelectrophoresis of human plasma apolipoproteins. Clin. Chem. 1984, 30, 2084-2092.
15. Karpe, F.; Hamsten, A. Determination of apolipoprotein B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 1994, 35, 1311-1317.
16. Gauss, C. et al. Analysis of the mouse proteome. Brain proteins: separation by two-dimensional gel electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis 1999, 20, 575-600.
17. Dayal, B.; Ertel, N. H. Matrix-assisted laser desorption/ionization mass spectrometry of apolipoproteins extracted directly from sodium dodecyl sulfate-polyacrylamide gels: studies performed in patients with diabetes and cardiovascular disease. Unpublished results.
18. Oka, T.; Kujiraoka, T.; Ito, M.; Nagano, M.; Ishihara, M.; Iwasaki, T.; Egashira, T.; Miller, N. E.; Hattori, H. Measurement of human phospholipid transfer protein by sandwich enzyme-linked immunosorbent assay. Clin. Chem. 2000, 46, 1357-1364.
19. Desrumaux, C.; Athias, A.; Bessede, G.; Verges, B.; Farnier, M.; Persegol, L.; Gambert, P.; Lagrost, L. Mass concentration of plasma Phospholipid Transfer Protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and noninsulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler. Thromb. 1999, 19, 266-275.
20. Guyard-Dangremont, V.; Lagrost, L.; Gambert, P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on Cholesteryl Ester Transfer Protein Activity. J. Lipid Res. 1994, 35, 982-992.
21. Jauhiainen, M.; Huuskonen, J.; Baumann, M.; Metso, J.; Kka, T.; Egashira, T.; Hattori, H.; Olkkonen, V. M.; Ehnholm, C. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I. J. Lipid Res. 1999, 40, 654-664.
22. Jauhiainen, M.; Ehnholm, C. Role of the phospholipid transfer protein (PLTP) in plasma lipid transport. In Advances in Vascular Biology: Plasma Lipids and Their Role in Disaese; Barter P. J., Rye, K. A., Eds.; Harwood Academic: Australia, 1999; pp 285-97.
23. Roy P.; MacKenzie, R.; Hirama T.; Jiang, X. C.; Kussie, P.; Tall, A.; Rassart, E.; Milne, R. Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies. J. Lipid Res. 1996, 37, 22-34.
24. Sviridov, D.; Hoang, A.; Sawyer; W.H.; Fidge N. H. Identification of a sequence of apolipoprotein A-I associated with the activation of lecithin:cholesterol acyltransferase. J. Biol. Chem. 2000, 275, 19707-19712.
25. Cho, K. H.; Jonas, A. A key point mutation (V156E) affects the structure and function of human apolipoprotein A-1. J. Biol. Chem. 2000, 275, 26821-26827.
26. Asztalos, B.; Wenwu, Z.; Roheim, P. S.; Wong, L. Role of free apolipoprotein A-I in cholesterol efflux. Arterioscler. Thromb. Vascu. Biol. 1997, 17, 1630-1636.
27. Maciejko, J. J. et al. Apolipoprotein A-I as a marker of angiographically assessed CAD. N. Engl. J. Med. 1983, 309, 385-389.
28. Dalton, M. B.; Swaney, J. B. Structural and functional domains of apolipoprotein A-I within high-density lipoproteins. J. Biol. Chem. 1993, 268, 19274-19283.
29. milano Atherosclerosis 1998, 136L, 139-146.
30. Francis, G. A.; Knopp, R. H.; Oram, J. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 1995, 96, 78-87.
31. Rye, K. A.; Clay, M. A.; Barter, P. J. Remodeling of high-density lipoproteins by plasma factors. Atherosclerosis 1999, 145, 227-238.
32. Dayal, B.; Li, Q.; Ertel, N. H. A facile mass spectral approach for the measurement and identification of apolipoproteins A-1 (apoA-1). 221st National Meeting of the American Chemical Society, San Diego, CA, April 2001; American Chemical Society: Washington, DC, 2001; Abstract 19 (Medicinal Chemistry Division).
33. Dayal, B.; Ertel, N. H. et al. The role of phospholipid transfer proteins in remodeled HDL and their identification via matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS). 40th Eastern Analytical Symposium & Exposition, Atlantic City, NJ, Oct 1-4, 2001, Abstract 282.
34. Davies, H.; Lomas, L.; Austen, B. Profiling of amyloid Beta peptide variants using SELDI ProteinChip arrays. Biotechniques 1999, 27, 1258-1261.
35. Li, X.; Mohan, S.; Gu, W.; Miyakoshi, N.; Baylink, D. J. Differential protein profile in the ear-punched tissue of regeneration and nonregeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration. Biochim. Biophys. Acta 2000, 1524, 102-109.
36. Wright, G. L., Jr.; Cazares, L. H.; Leung, S. M.; Nasim, S.; Adam, B. L.; Yip, T. T.; Schellhammer, P. F.; Gong, L.; Vlahou, A. ProteinChip surface enhanced laser desorption/ionization (SELDI) mass spectroscopy: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. 1999, 2, 264-276.
37. Dayal, B.; Ertel N. H.; Dang, A. Binding of apolipoprotein A-1 from human plasma to anti-apolipoprotein A-1 antibody and its measurement by Surface Enhanced Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (SELDI-TOF): (ProteinChip Technology). Manuscript in preparation.
38. Ehring, H.; Stromberg, S.; Tjernberg, A.; Noren, B. Matrix-assisted laser desorption ionization mass spectrometry of proteins extracted directly from sodium dodecyl sulphate-polyacrlyamide gels. Rapid Commun. Mass Spec. 1997, 11, 1867-1873.
39. Mirza, U. A.; Liu, Yan-Hui, Tang J. T.; Porter, F.; Bondoc, L.; Chen, G.; Pramanik, B. N.; Nagabhushan, T. L. Extraction and Characterization of Adenovirus Proteins From Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis by Matrix Assisted Laser Desorption/Ionization Mass Spectrometry. J. Am. Soc. Mass Spectrom. 2000, 11, 356-361.
40. Bondarenko, P. V.; Cockrill, S. L.; Watkins, L. K.; Cruzado, I. D.; Macfarlane, R. D. Mass spectral study of polymorphism of the apolipoproteins of very low-density lipoprotein. J. Lipid Res. 1999, 40, 543-555 and references therein.
41. Beavis, R. C.; Chair, B. T. Rapid, sensitive analysis of protein mixtures by mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6873-6877.
42. 0 lacks carbohydrates residue: use of mass spectrometry to study apolipoprotein structure. J. Lipid Res. 1998, 30, 1781-1787.
43. Gygi, S. P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 1999, 17, 994-999.
44. Lueking, A.; Horn, M.; Eickhoff, H.; Walter, G. Protein microarrays for gene expression and antibody screening. Anal. Biochem. 1999, 270, 103-111.
45. Witztum, J. L.; Fisher, M.; Pietro, T.; Steinbrecher, U. P.; Elam, R. L. Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs. Diabetes 1982, 31, 1029-1032.
46. Downs, J. R.; Clearfield, M.; Weis, S. et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998, 279, 161.
47. Scandinavian Simvastatin Survival Study Group. Lancet 1994, 344, 1383-9.
48. Shepherd, J.; Cobbe, S. M.; Ford, I.; Isles, C. G.; Lorimer, A. R. et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 1995, 333, 1301-7.